IL274931B2 - Process for the preparation of 2-(5-methoxyisochroman-1 -yl)-4,5-dihydro-1 h-imidazole and the hydrogensulfate salt thereof - Google Patents

Process for the preparation of 2-(5-methoxyisochroman-1 -yl)-4,5-dihydro-1 h-imidazole and the hydrogensulfate salt thereof

Info

Publication number
IL274931B2
IL274931B2 IL274931A IL27493120A IL274931B2 IL 274931 B2 IL274931 B2 IL 274931B2 IL 274931 A IL274931 A IL 274931A IL 27493120 A IL27493120 A IL 27493120A IL 274931 B2 IL274931 B2 IL 274931B2
Authority
IL
Israel
Prior art keywords
formula
methoxyisochroman
ethyl
compound
carboxylate
Prior art date
Application number
IL274931A
Other languages
English (en)
Hebrew (he)
Other versions
IL274931A (en
IL274931B1 (en
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of IL274931A publication Critical patent/IL274931A/en
Publication of IL274931B1 publication Critical patent/IL274931B1/en
Publication of IL274931B2 publication Critical patent/IL274931B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Epoxy Resins (AREA)
  • Detergent Compositions (AREA)
IL274931A 2017-12-01 2018-11-30 Process for the preparation of 2-(5-methoxyisochroman-1 -yl)-4,5-dihydro-1 h-imidazole and the hydrogensulfate salt thereof IL274931B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20176085 2017-12-01
PCT/FI2018/050864 WO2019106238A1 (en) 2017-12-01 2018-11-30 Process for the preparation of 2-(5-methoxyisochroman-1 -yl)-4,5-dihydro-1 h-imidazole and the hydrogensulfate salt thereof

Publications (3)

Publication Number Publication Date
IL274931A IL274931A (en) 2020-07-30
IL274931B1 IL274931B1 (en) 2023-07-01
IL274931B2 true IL274931B2 (en) 2023-11-01

Family

ID=64746580

Family Applications (1)

Application Number Title Priority Date Filing Date
IL274931A IL274931B2 (en) 2017-12-01 2018-11-30 Process for the preparation of 2-(5-methoxyisochroman-1 -yl)-4,5-dihydro-1 h-imidazole and the hydrogensulfate salt thereof

Country Status (19)

Country Link
US (1) US11352346B2 (enExample)
EP (1) EP3717476B1 (enExample)
JP (1) JP7339946B2 (enExample)
KR (1) KR102718536B1 (enExample)
CN (1) CN111630049B (enExample)
AU (1) AU2018376872B2 (enExample)
BR (1) BR112020010617A2 (enExample)
CA (1) CA3083734A1 (enExample)
DK (1) DK3717476T3 (enExample)
ES (1) ES2927193T3 (enExample)
HR (1) HRP20221247T1 (enExample)
HU (1) HUE059849T2 (enExample)
IL (1) IL274931B2 (enExample)
LT (1) LT3717476T (enExample)
PL (1) PL3717476T3 (enExample)
PT (1) PT3717476T (enExample)
SI (1) SI3717476T1 (enExample)
WO (1) WO2019106238A1 (enExample)
ZA (1) ZA202003981B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112020003658T5 (de) 2019-07-31 2022-05-19 Hyundai Motor Company Sdn-basiertes eindringungsverhinderungsverfahren für ein fahrzeuginternesnetz und system, das dieses verfahren verwendet
KR20230159515A (ko) * 2021-03-19 2023-11-21 오리온 코포레이션 타시피미딘 제형 및 이의 용도
JP2025502480A (ja) * 2022-01-24 2025-01-24 オリオン コーポレーション イソクロマン－イミダゾール構造のアルファ－２ａアドレナリン受容体アゴニストの新規な硫酸塩形
WO2023148431A1 (en) 2022-02-04 2023-08-10 Orion Corporation Novel salt forms of isochroman-imidazole structured alpha-2a adrenoceptor agonist
JP2025531623A (ja) 2022-09-28 2025-09-22 オリオン コーポレーション タシピミジンおよびｃｙｐ２ｄ６阻害薬の併用療法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013150173A1 (en) * 2012-04-02 2013-10-10 Orion Corporation New alpha2 adrenoceptor agonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410562B1 (en) * 1998-12-18 2002-06-25 Eli Lilly And Company Hypoglycemic imidazoline compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013150173A1 (en) * 2012-04-02 2013-10-10 Orion Corporation New alpha2 adrenoceptor agonists

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LOUGHLIN, WENDY A., IAN D. JENKINS, AND MARIA J. PETERSSON., CYCLODEHYDRATION OF N-(AMINOALKYL) BENZAMIDES UNDER MILD CONDITIONS WITH A HENDRICKSON REAGENT ANALOGUE., 31 December 2013 (2013-12-31) *
REVERDITO, ANA M., ISABEL A. PERILLO, AND ALEJANDRA SALERNO., SYNTHESIS AND SYNTHETIC APPLICATIONS OF 1-ARYL-2-ALKYL-4, 5-DIHYDRO-1 H-IMIDAZOLES., 31 December 2012 (2012-12-31) *

Also Published As

Publication number Publication date
US11352346B2 (en) 2022-06-07
HUE059849T2 (hu) 2023-01-28
US20200308152A1 (en) 2020-10-01
JP7339946B2 (ja) 2023-09-06
RU2020121597A3 (enExample) 2022-01-04
EP3717476B1 (en) 2022-08-03
LT3717476T (lt) 2022-09-26
AU2018376872B2 (en) 2023-12-07
CN111630049A (zh) 2020-09-04
IL274931A (en) 2020-07-30
ES2927193T3 (es) 2022-11-03
HRP20221247T1 (hr) 2022-12-09
EP3717476A1 (en) 2020-10-07
BR112020010617A2 (pt) 2020-11-10
RU2020121597A (ru) 2022-01-04
KR102718536B1 (ko) 2024-10-21
PT3717476T (pt) 2022-08-23
SI3717476T1 (sl) 2022-10-28
WO2019106238A1 (en) 2019-06-06
JP2021504418A (ja) 2021-02-15
CA3083734A1 (en) 2019-06-06
AU2018376872A1 (en) 2020-07-16
PL3717476T3 (pl) 2022-11-21
IL274931B1 (en) 2023-07-01
KR20200095519A (ko) 2020-08-10
CN111630049B (zh) 2023-06-20
DK3717476T3 (da) 2022-09-05
ZA202003981B (en) 2021-07-28

Similar Documents

Publication Publication Date Title
EP3717476B1 (en) Process for the preparation of 2-(5-methoxyisochroman-1-yl)-4,5-dihydro-1h-imidazole and the hydrogensulfate salt thereof
CN111448192B (zh) 用于制备驱蠕虫的4-氨基-喹啉-3-甲酰胺衍生物的方法
EA018227B1 (ru) Способ получения дабигатрана и его промежуточные соединения
EP3668857B1 (en) Processes for the preparation of niraparib and intermediates thereof
JP2005507900A (ja) シタロプラムの製造方法
EP2958894A1 (en) Process for the preparation of enantiomerically enriched 3-aminopiperidine
JP2020518661A5 (enExample)
JP2025026621A (ja) シス－（－）－フロシノピペリドールの製造方法
US12522554B2 (en) Method for preparing intermediate for synthesis of sphingosine-1-phosphate receptor agonist
RU2791469C2 (ru) Способ получения 2-(5-метоксиизохроман-1-ил)-4,5-дигидро-1h-имидазола и его гидросульфата
EP2421853B1 (en) Synthesis of 3-{[(2r)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1h-indole
WO2011060624A1 (en) Process for preparing 2-methyl-4-amino-5-cyanopyrimidine
RU2804710C2 (ru) Способ получения антигельминтных 4-амино-хинолин-3-карбоксамидных производных
EP2785681A1 (en) Process for the preparation of agomelatine
JP6660393B2 (ja) ４−シアノピペリジン塩酸塩を調製する方法
EP2462144B1 (en) PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
KR20250054096A (ko) p-니트로벤조산-2-에틸헥실 에스테르를 제조하기 위한 개선된 방법
WO2010064212A1 (en) Method for obtaining an optically pure 1,2,3,4 tetrahydro-isoquinoline derivative
BR112020011901B1 (pt) Processo para preparar derivados anti-helminticos de 4-aminoquinolina-3-carboxamida
JP2001247549A (ja) １位置換ヒダントイン類の製造方法